Alexandros Michailidis/iStock Editorial via Getty Images Pfizer ( NYSE: PFE ) has voluntarily withdrawn all lots of its sickle cell disease drug Oxbryta, also known as voxelotor, over safety concerns. “Pfizer's decision is based on the totality of clinical data that now indicates the overall benefit of Oxbryta no.
Back to Health Page
